Gabapentin gets half billion dollar criminal fine for Pfizer for off-licence use

[Spiritfree]

Otter -it is ALL about the money. But please rest assured, Baclofen will one day have it's day in court -and all will see that it is the 'only' drug known that effects the GABBA-b the way that it does. Unfortunately, all of the AUD scientist know this but this is not where the money is. So, our best hope for now is for the government is to get Gabapentin into the spotlight and then watch as Baclofen takes over.

[Otter]

I don't think it really matters much what happens with Gabapentin. It's not a competition.

Here is an email from Olivier Ameisen:


AUG
17
E-mail from Dr Olivier Ameisen to the Media explaining the conflict between labs , pharma lobbies and corrupted Drs against the use of baclofen on addictions


E-mail from Dr Olivier Ameisen to the Media explaining the conflict between labs and labbies against the use of baclofen on addictions:







In the memory of Joshua Lederberg and Jean Dausset, both Nobel laureates for medicine who have been both my friends and intellectual mentors and for Dausset and to my brother Jean-Claude, whom have understood and publically hailed my findings, which they publically call discovery as early as 2004...

... a humble thank you! In doing so, you have allowed thousands of patients worldwide a cure for addictions and related behavior’s such as bulimia/binge-eating disorders etc.
Without the indefectible support of you journalists, nothing would have happened!

Dear patients who are at my call in the last chapter of my book grouping into patients' associations. Not only are you cured for many years by me or physicians whom I have personally trained, or others like those at the University of Melbourne who have published four out of four cases of complete suppression of the disease in Journal of Psychopharmacology.
When other doctors claim a mediocre or poor success rate, as some brag about in the media, they should not be permitted to use my treatment method. Any patient with common sense will pick a doctor with a high-success rate.
As a cardiologist, I can assure you that for a cardiac surgeon who has a >3% mortality/complication rate, she/he will be prohibited by New York State, to perform that kind of surgery.
Like with all medical/surgical treatments, the rates of success are operator-dependent and doctors with poor results should be barred from incompetent prescribing. Were I to report only a 50% of success in my patients wiyh high-blood pressure, I would be declared a dilettante and be prohibited to practice medicine altogether.

And on March 14, on the Ohio based Louie B. Free Radio show*, between 3 and 5pm EST, I shall deliver breaking news and publicly expose the US Government's National Agency, the Food An Drug Administration (FDA) for conflicts of interest and explain why "high-dose baclofen", that I have evidence from my own patients and colleagues who have replicated my findings as described in 2004/5 in Alcohol and Alcoholism and JAMA safely suppresses food craving (as I have described - papers in press in a leading medical journal).
* http://www.vindy.com/louie-free/
You can listen to the radio show live .

At his request, I have invited Dr Richard Falzone on the show.
Dr Falzone is an instructor in the department of psychiatry and of the department of addiction medicine at Harvard Medical School's McLean's Hospital at which, on April 14, 2009, I gave a talk. At the invitation of my distinguished colleague Roger Weiss, head of psychiatry and addiction medicine at Harvard to give a talk in Bostonhad invited me to give a talk, after he heard of te spin I gave to my treatment in my talks at Columbia, NYU, SUNY etc. I had to decline the invitation to talk in October 2009 because I had a previously scheduled engagement with U. Berlin and postpone it to April 2010, which Harvard graciously accepted.
Dr Weiss later told me that due to lack of funding, he won't be able to conduct a randomized trial. This has been said to me by nearly every leading physician in academia, in the USA as well as in Europe.
NIH, like FDA are US government agencies.
When I pay my US taxes, I cannot accept that my taxpayers' money goes into such agencies that are blocking my high-dose baclofen treatment, due to often unconscious conflicts of interest. With my taxes, they are funding or approving

Does what I say sound like a "h'accuse" by Emile Zola? If it looks like a duck, it walks like a duck and quack like a duck, it sure is a "j'accuse" but I am only an average scientist/physician where Zola is one of the great writers!

The backing of Harvard is major for me in the sense that it lends additional credibility to my work which has life-saving consequences to patients. Let us be reminded that in the US alone, addiction to alcohol leads to the daily death of 300 patients. This is more than any single cancer. This does not take into account the number of deaths from addiction to licit or illicit drugs such as opiates legal or illegal), cocaine, nicotine etc.
I have completely eliminated such addictions in my own patients, as well as binge-eating-bulimia.
My patients loose sometimes up to 50% of their body weight and maintain this for years.

Illustrious scientists such Barry Marshall, the professor of microbiology who self-experimented with H. Pylori have inspired me to, in addition to publishing papers in academic journals, use the media widely to help desperate patients. Medical journals are the only place to lend the seal of credibility to scientific research. But the media is fast in echoing it. It is a remarkable sound box in the sense that it goes straight to patients and their loved ones. Academic papers are rightly so, rather slowish, because of the necessary peer-reviewing system.
So by following the footspets of my distinguishes eldest, I feel that it is legitimate for me to give advance notice to the media that has already helped saving thousands of lives of instantly helps saving lives and alleviating torture in tens of thousands of patients.
The sequence is my book -> media coverage -> patients having their GPs read my book, their physicians using Ameisen's treatment method and as a result, physicians prescribing my exact protocol and in addiction to reporting it in medical journals, are routinely using HD baclofen in thousands of of patients. The process is exponential, thanks to the media coverage.

Cheers,
Dr Olivier Ameisen

[Otter]

Jean-Claude Ameisen is the brother of Olivier Ameisen and is a physician and researcher, professor of immunology at the University of Paris Diderot. His research mainly concerned the origin of cellular self-destruction phenomena in the evolution of life and the role of "programmed cell death" in the development of disease.

Committed to ethical reflection he has been,since November 2012, president of the National Consultative Ethics Committee (CCNE), he chaired the Ethics and Scientific Committee of the International Foundation for Applied Research on Disability (FIRAH) and the Ethics Committee of Inserm.

Involved in the development of relations between science, culture and society, he is director of the Center for Life Studies (Institute of Humanities of Paris - University Paris Diderot) and member of the Scientific Council of the International College of Philosophy.

He is supporting the licensing of baclofen for alcoholism so it is "in the bag" that it will be licensed and merely a matter of chance that Ameisen was French and that they will approve it first.

I have no doubt that Koob and the NIH will follow suit in the US and the only thing stopping approval in France is getting the paperwork in to the government which is expected in the new year.

[Spiritfree]

Yes Otter, Baclofen will soon be approved in France for AUD and hopefully the USA will follow suit. The important part about Gabapentin being a part of all of this is the fact that it has been around for years too -just like Baclofen- and is written off label -just like Baclofen- for AUD. If Gabapentin makes it to the doctors knowledgebase, then so will Baclofen. We have just got to keep writing and notifying.